Root Financial Partners
LGND icon

Root Financial Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Root Financial Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.6K Buy
+34
New +$10K ﹤0.01% 1882
2026
Q2 		– Sell
-19
Closed -$3.79K – 1955
2026
Q1 		$3.79K Buy
19
+12
+171% +$2.37K ﹤0.01% 2054
2025
Q4 		$1.32K Buy
+7
New +$1.34K ﹤0.01% 2056

Other funds holding LGND

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Root Financial Partners's LGND Position: Q3 2026 in Review

Root Financial Partners opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 34 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #1882 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in LGND as recently as Q1 2026.

Root Financial Partners first reported a position in LGND in Q4 2025 and has held it in 3 quarters since. 342 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Root Financial Partners held 34 shares of Ligand Pharmaceuticals worth $10.6K as of Q3 2026.
  • Ligand Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1882 holding.
  • Root Financial Partners first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 342 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.